Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > nanoTox Chief Scientific Officer, Dr. David W. Hobson, to Speak on Nanotech Policy, Regulation and Product Safety at NSTI Nanotech

Abstract:
nanoTox Inc., the first company to provide complete risk assessment - and solutions - exclusively for nanoparticles, announced today that its Chief Scientific Officer, Dr. David W. Hobson, will share his insight on impending regulations and policies surrounding nanotech product safety during the NSTI Nanotech conference and exposition in Houston, Texas. The panel, entitled "Nanotech Policy, Regulation and Product Safety," will take place at 1:30 p.m. on May 5, 2009 at the George R. Brown Convention Center.

nanoTox Chief Scientific Officer, Dr. David W. Hobson, to Speak on Nanotech Policy, Regulation and Product Safety at NSTI Nanotech

Houston, TX | Posted on April 23rd, 2009

Dr. Hobson is a toxicological expert on safety issues related to the commercialization of nanotechnology and is a noted consultant to government and industry on nanoproduct and nanotechnology development issues.

"The nanotechnology platform is demonstrating amazing potential for the development of advanced technologies and products in many business sectors," stated Dr. Hobson. "Recent actions in the U.S. and abroad requiring nanotechnology companies to list certain materials they incorporate into commercial products are just the start of events that will have lasting effects on nanotechnology companies and the marketplace for nanoproducts."

Dr. Hobson has 30 years of practical experience in toxicological research and development, including environmental, industrial, and medical projects for government, industry and private concerns. His experience with nanomaterials includes pharmacological and toxicological research using in vitro and in vivo pre-clinical models; preparation of medical device submissions to regulatory agencies, as well as chemistry and manufacturing controls and pharmacology/toxicology sections for new drug applications. His work with nanoTox includes establishing state-of-the-art facilities and test procedures, which are employed for clients under strict confidentiality and in accordance with established U.S. good laboratory practices and international data quality standards.

Dr. Hobson is a past president of the American College of Toxicology and an editorial advisor to the International Journal of Toxicology. He teaches courses in biophysics, nuclear pharmacy, immunoassay and radiation biology at the University of the Incarnate Word in San Antonio.

Dr. Hobson has many scientific publications to his credit including the book Dermal and Ocular Toxicology: Fundamentals and Methods; and book chapters on product risk assessment, toxicology study design, toxicology of wound healing, dermal toxicology and gastrointestinal toxicology. He has led successful projects including all aspects of pharmaceutical development - from discovery, development and registration to post-market support - which have resulted in currently marketed pharmaceutical products and numerous patents.

nanoTox will be exhibiting at the NSTI Nanotech conference and exposition May 3-7, 2009. The nanoTox booth, #907, will be located near the front of the exhibit hall.

####

About nanoTox Inc.
nanoTox is the first company to provide complete risk assessment – and solutions – exclusively for nanoparticles. nanoTox determines the toxicity of its clients’ nanoproducts and offers strategies for managing, reducing or eliminating risk to meet state and federal safety guidelines and shorten time to market. Because nanoTox uses methodologies that are performed under recognized international data quality standards (GLP, ISO, etc.) in its laboratories, the results and associated assessments are suitable for use to support regulatory decisions, product registrations, litigation, and for acceptance by the insurance industry.

nanoTox ensures complete client confidentiality for all of its clients, which include companies or entities that require government approval to market their nanoproducts, venture capital firms that invest in nanoproduct companies, law firms engaged by such companies and insurance companies considering insuring such companies from liability.

nanoTox is headquartered in Austin, Texas, with offices in Maastricht, Netherlands.

About NSTI
The Nano Science and Technology Institute (NSTI; www.nsti.org) advances and integrates nano and other advanced technologies through education, conventions, business publishing, and research services. NSTI produces the annual Nanotechnology conference and trade show, which attracts more than 5,000 industrial, academic, business and governmental attendees from around the world. It is the largest gathering of the nanotechnology industry in the U.S. NSTI was founded in 1997 as a result of the merger between various scientific societies, and is headquartered in Cambridge, Massachusetts with offices in California and Switzerland.

For more information, please click here

Contacts:
Laura P. Wright
CameronWeeks Public Relations
The Premium PR Agency for Complex Technologies & Industries
Tel. 512.461.5777

www.cameronweeks.com

Copyright © nanoTox Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

Govt.-Legislation/Regulation/Funding/Policy

UT engineers develop first method for controlling nanomotors: Breakthrough for nanotechnology as UT engineers develop first method for switching the mechanical motion of nanomotors September 21st, 2018

Researchers develop microbubble scrubber to destroy dangerous biofilms September 19th, 2018

Researchers managed to prevent the disappearing of quantum information September 14th, 2018

New photonic chip promises more robust quantum computers September 14th, 2018

Announcements

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

Safety-Nanoparticles/Risk management

Silver nanoparticles are toxic for aquatic organisms: A research team at the UPV/EHU-University of the Basque Country has analysed how zebrafish are affected in the long term by exposure to silver particles September 19th, 2018

Carbon nanodots do an ultrafine job with in vitro lung tissue: New experiments highlight the role of charge and size when it comes to carbon nanodots that mimic the effect of nanoscale pollution particles on the human lung. September 12th, 2018

A human enzyme can biodegrade graphene August 28th, 2018

Nanoscience and the future of healthcare kick off first day of ACS national meeting in Boston: Presidential events highlight safety, diversity and groundbreaking research August 2nd, 2018

Events/Classes

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018 September 20th, 2018

Arrowhead Pharmaceuticals to Present at Upcoming September 2018 Conferences August 31st, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project